Regeneron Pharmaceuticals is a biotechnology company focused on discovering, developing, and commercializing medicines for serious diseases. Their core business model centers around research and development, manufacturing, and commercialization of innovative therapies, primarily in the areas of eye diseases, allergic and inflammatory conditions, cancer, and cardiovascular and metabolic disorders. Regeneron maintains a strong market position with a focus on scientific research and discovery, with a geographic presence in the United States, Europe, and Japan.